ViroGates Enters Into a Long-Term Research Collaboration with Hvidovre Hospital

ViroGates A/S has entered into a long-term research collaboration with the Hvidovre Hospital's Clinical Research Centre. The agreement will continue to support the commercialization of the company's suPAR technology.

ViroGates and Hvidovre Hospital have since 2001 had close ties and have collaborated on various studies and projects. This work has in 2006 led to a new patent application that ViroGates has licensed from Hvidovre Hospital. Now the two organizations have formalized their relationship further into a long-term research agreement to continue to collaborate on clinical work relating to suPAR and its applications.

- The research collaboration with ViroGates is of special importance to us. As scientists, we are proud when our research successfully develops into a commercial product. It is a great reward to see how ViroGates is taking the suPAR technology to the market with the suPARnostic® product, says Ove Andersen, Research Director, Clinical Research Centre, Hvidovre Hospital.

Read the full press release.

Source: Press release, ViroGates, 07.05.2008